Evaluation of changing the pattern of CTRP5 and inflammatory markers levels in patients with coronary artery disease and type 2 diabetes mellitus

References

• ADA, 2019. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes care, 42, S13–S28.
   PubMed Web of Science ®Google Scholar
• Ban, B., et al., 2014. Low serum cartonectin/CTRP3 concentrations in newly diagnosed type 2 diabetes mellitus: in vivo regulation of cartonectin by glucose. PLoS one, 9 (11), e112931.
   PubMed Web of Science ®Google Scholar
• Çalan, M., et al., 2019. Association of decreased C1q/tumor necrosis factor-related protein-5 levels with metabolic and hormonal disturbance in polycystic ovary syndrome. Journal of the Turkish-German gynecological association, 20 (2), 89–96.
   PubMed Web of Science ®Google Scholar
• Cao, H., 2014. Adipocytokines in obesity and metabolic disease. Journal of endocrinology, 220 (2), T47–T59.
   PubMed Web of Science ®Google Scholar
• Dadmanesh, M., et al., 2018. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. PLoS one, 13 (9), e0204180.
   PubMed Web of Science ®Google Scholar
• Einarson, T.R., et al., 2018. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovascular diabetology, 17 (1), 83.
   PubMed Web of Science ®Google Scholar
• Emamgholipour, S., et al., 2015a. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study. Diabetology & metabolic syndrome, 7, 108–108.
   PubMed Web of Science ®Google Scholar
• Emamgholipour, S., et al., 2015b. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study. Diabetology & metabolic syndrome, 7 (1), 108.
   PubMed Web of Science ®Google Scholar
• Fadaei, R., et al., 2016. Association of C1q/TNF-related protein-3 (CTRP3) and CTRP13 serum levels with coronary artery disease in subjects with and without type 2 diabetes mellitus. PLoS one, 11 (12), e0168773.
   PubMed Web of Science ®Google Scholar
• Fadaei, R., et al., 2019. Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance. Cytokine, 113, 326–331.
   PubMed Web of Science ®Google Scholar
• Hajer, G.R., van Haeften, T.W., and Visseren, F.L.J., 2008. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European heart journal, 29 (24), 2959–2971.
   PubMed Web of Science ®Google Scholar
• Jiang, F., et al., 2018. C1q/TNF-related protein5 (CTRP5) as a biomarker to predict metabolic syndrome and each of its components. International journal of endocrinology, 2018, 1–8.
   Google Scholar
• Lei, X., et al., 2016. Loss of CTRP5 improves insulin action and hepatic steatosis. American journal of physiology-endocrinology and metabolism, 310 (11), E1036–E1052.
   PubMed Web of Science ®Google Scholar
• Leon, B.M., and Maddox, T.M., 2015. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World journal of diabetes, 6 (13), 1246–1258.
   PubMed Web of Science ®Google Scholar
• Li, D., et al., 2015. Adipokine CTRP-5 as a potential novel inflammatory biomarker in chronic obstructive pulmonary disease. Medicine (Baltimore), 94 (36), e1503.
   PubMed Web of Science ®Google Scholar
• Mahmoudi, M., et al., 2017. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. International journal of rheumatic diseases, 20, 287–297.
   PubMed Web of Science ®Google Scholar
• Moradi, N., et al., 2018. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease. PLoS one, 13 (1), e0192159.
   PubMed Web of Science ®Google Scholar
• Park, S.Y., et al., 2009. C1q tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase. Journal of biological chemistry, 284 (41), 27780–27789.
   PubMed Web of Science ®Google Scholar
• Rao, C., et al., 2019. The novel adipokine CTRP5 is a negative regulator of white adipose tissue browning. Biochemical and biophysical research communications, 510 (3), 388–394.
   PubMed Web of Science ®Google Scholar
• Samuel, V.T., and Shulman, G.I., 2016. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Journal of clinical investigation, 126 (1), 12–22.
   PubMed Web of Science ®Google Scholar
• Schaffler, A., and Buechler, C., 2012. CTRP family: linking immunity to metabolism. Trends in endocrinology and metabolism, 23, 194–204.
   PubMed Web of Science ®Google Scholar
• Schmid, A., et al., 2013. Regulation and function of C1Q/TNF-related protein-5 (CTRP-5) in the context of adipocyte biology. Experimental and clinical endocrinology & diabetes, 121, 310–317.
   PubMed Web of Science ®Google Scholar
• Seldin, M.M., Tan, S.Y., and Wong, G.W., 2014. Metabolic function of the CTRP family of hormones. Reviews in endocrine and metabolic disorders, 15, 111–123.
   PubMed Web of Science ®Google Scholar
• Shen, Y., et al., 2017. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells. International journal of cardiology, 228, 129–136.
   PubMed Web of Science ®Google Scholar
• Shokoohi Nahrkhalaji, A., et al., 2019. Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance. Archives of physiology and biochemistry, 1–5.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2016. Serum levels of C1q/TNF-related protein-1 (CTRP-1) are closely associated with coronary artery disease. BMC cardiovascular disorders, 16 (1), 92.
   PubMedGoogle Scholar
• Wong, G.W., et al., 2008. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochemical journal, 416 (2), 161–177.
   PubMed Web of Science ®Google Scholar
• Yamada, Y., et al., 2007. Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. Journal of medical genetics, 45 (1), 22–28.
   PubMed Web of Science ®Google Scholar
• Yang, W.-M., Min, K.-H., and Lee, W., 2015. C1q tumor necrosis factor α-related protein isoform 5 attenuates palmitate-induced DNA fragmentation in myocytes through an AMPK-dependent mechanism. Data in brief, 5, 770–774.
   PubMed Web of Science ®Google Scholar